Search

Search results

21 results found

A Pilot Randomized Trial on Safety and Efficacy of a Novel Topical Combined Inhibitor of Janus Kinase 1/3 and Spleen Tyrosine Kinase for GVHD-Associated Ocular Surface Disease

Kheirkhah, Ahmad, Antonio Di Zazzo, Vannarut Satitpitakul, Merle Fernandez, Daniel Magilavy, and Reza Dana. 2017. “A Pilot Randomized Trial on Safety and Efficacy of a Novel Topical Combined Inhibitor of Janus Kinase 1/3 and Spleen Tyrosine Kinase for GVHD-Associated Ocular Surface Disease”. Cornea 36 (7): 799-804.

Systemic therapy outperforms intraocular implant for treating uveitis

After seven years, multi-center clinical trial finds systemic therapy better preserves visual acuity and has fewer side effects Boston, Mass. — Systemic therapy consisting of corticosteroids and immunosuppressants preserved vision of uveitis patients better – and had fewer adverse outcomes – than a...

Eli Peli joins Board of Directors for non-profit ride service

Eli Peli, MSc, OD, has joined the board for directors of ITN America. This non-profit provides ride services for the elderly and visually impaired. They support sustainable, community-based transportation services for seniors throughout the world by building a senior transportation network through...